Clinical significance of angiogenesis in gastric carcinoma as a predictive marker for recurrence
Maeda, K.; Chung, Y.S.; Takatsuka, S.; Ogawa, Y.; Onoda, N.; Arimoto, Y.; Nitta, A.; Sawada, T.; Kato, Y.; Sowa, M.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(8): 1283-1285
1994
ISSN/ISBN: 0385-0684 PMID: 7518222 Document Number: 425304
Document emailed within 1 workday
Related Documents
Siddiqui, G.K.; Elmasry, K.; Wong Te Fong, A.C.; Perrett, C.; Morris, R.; Crow, J.C.C.; Maclean, A.B. 2010: Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer European Journal of Gynaecological Oncology 31(2): 156-159Okholm, C.; Thorsteinsson, M.; Achiam, M.P. 2014: Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer Ugeskrift for Laeger 176(32): 1490-1493
Maláska, J.; Kunická, Z.; Borský, M.; Sklenicková, M.; Novotná, M.; Fajkusová, L.; Zaloudík, J.; Fajkus, J. 2004: Telomerase as a diagnostic and predictive marker in colorectal carcinoma Neoplasma 51(2): 90-96
Li, Y.; Yang, Y.; Lu, M.; Shen, L. 2011: Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer Hepato-Gastroenterology 58(112): 2166-2170
Yeh, J-Lin.; Peng, Y-Chun.; Tung, C-Fang.; Yang, D-Yu.; Hu, W-Hsiung.; Chow, W-Keung.; Yeh, H-Zen.; Chen, G-Hum. 2003: Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma Hepato-Gastroenterology 50(53): 1603-1608
Zhang, H.-Y.; Tao, H.-M.; Chen, H.-T. 2011: Expression and clinical significance of epidermal growth factor receptor and protein kinase B in gastric carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 14(2): 140-142
Lee, T.; Tanaka, H.; Ohira, M.; Kubo, N.; Sakurai, K.; Toyokawa, T.; Muguruma, K.; Yamashitaz, Y.; Maeda, K.; Hirakawa, K. 2014: Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus Hepato-Gastroenterology 61(133): 1235-1240
Ren, T.-w.; Zhou, Y.-n.; Wu, J.; Zhang, Z.-y.; Hao, T.-j.; Wang, J.-x.; Zou, S.-j.; Chen, Z.-f.; Huang, S.-S.; Zhang, L.-H.; Zhao, Y. 2009: Relationship between Ets-1 expression and angiogenesis, clinicopathological features and survival of patients with gastric carcinoma Zhonghua Zhong Liu Za Zhi 31(9): 674-678
Husemann, B.; Giedl, J. 1982: Recurrence of gastric carcinoma Minerva Chirurgica 37(4): 279-282
Xie, J.-w.; Huang, C.-m.; Zheng, C.-h.; Li, P.; Wang, J.-b.; Lin, J.-x.; Lu, J. 2013: Expression tumor stem cell surface marker CD44 in gastric cancer and its significance Zhonghua Wei Chang Wai Ke Za Zhi 16(11): 1107-1112
Honig, A.; Schaller, N.; Dietl, J.; Backe, J.; Kammerer, U. 2005: S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma Anticancer Research 25(3a): 1747-1753
Janssen, C.W.; Tønder, O.; Matre, R. 1987: Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma Cancer Detection and Prevention 10(3-4): 303-309
Hara, K.; Mitsuhashi, F.; Ohkura, H. 1990: Clinical significance of CA 50 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 971-973
Barbui, T.; Finazzi, G.; Galli, M. 1997: Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 12(2): 76-83
Kato, H. 1990: Clinical significance of SCC antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1057-1059
Kubota, S. 1990: Clinical significance of polyamine assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 953-956
Kimura, T.; Nawata, H. 1990: Clinical significance of elastase 1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 899-902
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Yoshikawa, T.; Suzuki, K.; Kobayashi, O.; Sairenji, M.; Motohashi, H.; Yanoma, S.; Noguchi, Y.; Tsuburaya, A. 1998: Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1461-1464
Wang, H.-f.; Wu, A.-W.; Yuan, P.; Liu, Y.-q.; Ji, J.-f. 2011: Gastric neuroendocrine carcinoma and gastric carcinoma with neuroendocrine cell differentiation: a clinical and prognostic analysis Zhonghua Wei Chang Wai Ke Za Zhi 14(2): 96-99